Biogen Presents Positive Results From Phase 2 IGNAZ Study Of Felzartamab In Iga Nephropathy At American Society Of Nephrology (ASN) Kidney Week 2024
https://menafn.com/1108821056/Biogen-Presents-Positive-Results-From-Phase-2-IGNAZ-Study-Of-Felzartamab-In-Iga-Nephropathy-At-American-Society-Of-Nephrology-ASN-Kidney-Week-2024
NostrNewsNetwork / N₃ - Nostr News Network
npub1cp…9k7wp
2024-10-27 02:33:53 GMT
Author Public Key
npub1cpcchrazrgq9qlwrpkachs3xe6klvtntjhlf4x88frjl535ucjysp9k7wpPublished at
2024-10-27 02:33:53 GMTEvent JSON
{
"id": "5697deb83bf019c5a8c00229473263f1c83ddcda3dee78720895084564be567e",
"pubkey": "c0718b8fa21a00507dc30dbb8bc226ceadf62e6b95fe9a98e748e5fa469cc489",
"created_at": 1729996433,
"kind": 1,
"tags": [
[
"title",
"Biogen Presents Positive Results From Phase 2 IGNAZ Study Of Felzartamab In Iga Nephropathy At American Society Of Nephrology (ASN) Kidney Week 2024"
],
[
"image",
""
]
],
"content": "Biogen Presents Positive Results From Phase 2 IGNAZ Study Of Felzartamab In Iga Nephropathy At American Society Of Nephrology (ASN) Kidney Week 2024\n\nhttps://menafn.com/1108821056/Biogen-Presents-Positive-Results-From-Phase-2-IGNAZ-Study-Of-Felzartamab-In-Iga-Nephropathy-At-American-Society-Of-Nephrology-ASN-Kidney-Week-2024",
"sig": "7ef7859a72ecdbd8493a2587c980faee93169175970a556e51079291b6cbaced9255383d50a7e324c46fc7f150b5fc5f4825e34eaa3227ceefdfe7ace888453a"
}